Van Houte Hans
Chief Financial Officer
Sale
Calculated transaction value
$50.76K
3,300 shares @ $15.38
Traded
Nov 4, 2026
Filed
Nov 4, 2026
You're reading the free version. Trader adds the live tape and alerts.
Start tracking
Nurix Therapeutics
NRIX
ManufacturingChemicals
Transactions reported in official disclosures
Price with disclosed trades
Daily closes, past year · marks sit on transaction dates, sized by value
92 trades
| Reporting person | Filed | Transaction | Transaction value | Source | Actions |
|---|---|---|---|---|---|
| Van Houte Hans Chief Financial Officer | Nov 4, 2026 Same-day filing | Sale Nov 4, 2026 | $50.76K Filed shares x price | SEC Form 4 View filing | |
| Van Houte Hans Chief Financial Officer | Nov 4, 2026 Same-day filing | Sale Nov 4, 2026 | $23.8K Filed shares x price | SEC Form 4 View filing | |
| Ring Christine Chief Legal Officer | Nov 4, 2026 1-day lag | Sale Nov 3, 2026 | $157.92K Filed shares x price | SEC Form 4 View filing | |
| Ring Christine Chief Legal Officer | Nov 4, 2026 2-day lag | Sale Nov 2, 2026 | $28.77K Filed shares x price | SEC Form 4 View filing | |
| Ring Christine Chief Legal Officer | Nov 4, 2026 2-day lag | Exercise Nov 2, 2026 | $50.45K Filed shares x price | SEC Form 4 View filing | |
| Ring Christine Chief Legal Officer | Nov 4, 2026 2-day lag | Exercise Nov 2, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Ring Christine Chief Legal Officer | Nov 4, 2026 2-day lag | Sale Nov 2, 2026 | $245.22K Filed shares x price | SEC Form 4 View filing | |
| Van Houte Hans Chief Financial Officer | Nov 2, 2026 3-day lag | Exercise Oct 30, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Van Houte Hans Chief Financial Officer | Nov 2, 2026 3-day lag | Exercise Oct 30, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Van Houte Hans Chief Financial Officer | Nov 2, 2026 3-day lag | Exercise Oct 30, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Van Houte Hans Chief Financial Officer | Nov 2, 2026 3-day lag | Exercise Oct 30, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Van Houte Hans Chief Financial Officer | Nov 2, 2026 3-day lag | Exercise Oct 30, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Van Houte Hans Chief Financial Officer | Nov 2, 2026 3-day lag | Exercise Oct 30, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Van Houte Hans Chief Financial Officer | Nov 2, 2026 3-day lag | Sale Oct 30, 2026 | $74.47K Filed shares x price | SEC Form 4 View filing | |
| Ring Christine Chief Legal Officer | Nov 2, 2026 3-day lag | Exercise Oct 30, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Ring Christine Chief Legal Officer | Nov 2, 2026 3-day lag | Sale Oct 30, 2026 | $103.99K Filed shares x price | SEC Form 4 View filing | |
| Ring Christine Chief Legal Officer | Nov 2, 2026 3-day lag | Exercise Oct 30, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Ring Christine Chief Legal Officer | Nov 2, 2026 3-day lag | Exercise Oct 30, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Ring Christine Chief Legal Officer | Nov 2, 2026 3-day lag | Exercise Oct 30, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Ring Christine Chief Legal Officer | Nov 2, 2026 3-day lag | Exercise Oct 30, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Ring Christine Chief Legal Officer | Nov 2, 2026 3-day lag | Exercise Oct 30, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Hansen Gwenn Chief Scientific Officer | Nov 2, 2026 Same-day filing | Exercise Nov 2, 2026 | $2.7K Filed shares x price | SEC Form 4 View filing | |
| Hansen Gwenn Chief Scientific Officer | Nov 2, 2026 Same-day filing | Sale Nov 2, 2026 | $38.91K Filed shares x price | SEC Form 4 View filing | |
| Hansen Gwenn Chief Scientific Officer | Nov 2, 2026 Same-day filing | Exercise Nov 2, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Hansen Gwenn Chief Scientific Officer | Nov 2, 2026 3-day lag | Exercise Oct 30, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Hansen Gwenn Chief Scientific Officer | Nov 2, 2026 3-day lag | Sale Oct 30, 2026 | $103.99K Filed shares x price | SEC Form 4 View filing | |
| Hansen Gwenn Chief Scientific Officer | Nov 2, 2026 3-day lag | Exercise Oct 30, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Hansen Gwenn Chief Scientific Officer | Nov 2, 2026 3-day lag | Exercise Oct 30, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Hansen Gwenn Chief Scientific Officer | Nov 2, 2026 3-day lag | Exercise Oct 30, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Hansen Gwenn Chief Scientific Officer | Nov 2, 2026 3-day lag | Exercise Oct 30, 2026 | $0 Filed shares x price | SEC Form 4 View filing |
Van Houte Hans
Chief Financial Officer
Sale
Calculated transaction value
$23.8K
1,469 shares @ $16.2
Traded
Nov 4, 2026
Filed
Nov 4, 2026
Ring Christine
Chief Legal Officer
Sale
Calculated transaction value
$157.92K
6,113 shares @ $25.83
Traded
Nov 3, 2026
Filed
Nov 4, 2026
Ring Christine
Chief Legal Officer
Sale
Calculated transaction value
$28.77K
1,075 shares @ $26.76
Traded
Nov 2, 2026
Filed
Nov 4, 2026
Ring Christine
Chief Legal Officer
Exercise
Calculated transaction value
$50.45K
5,786 shares @ $8.72
Traded
Nov 2, 2026
Filed
Nov 4, 2026
Ring Christine
Chief Legal Officer
Exercise
Calculated transaction value
$0
5,786 shares @ $0
Traded
Nov 2, 2026
Filed
Nov 4, 2026
Ring Christine
Chief Legal Officer
Sale
Calculated transaction value
$245.22K
9,527 shares @ $25.74
Traded
Nov 2, 2026
Filed
Nov 4, 2026
Van Houte Hans
Chief Financial Officer
Exercise
Calculated transaction value
$0
3,750 shares @ $0
Traded
Oct 30, 2026
Filed
Nov 2, 2026
Van Houte Hans
Chief Financial Officer
Exercise
Calculated transaction value
$0
3,573 shares @ $0
Traded
Oct 30, 2026
Filed
Nov 2, 2026
Van Houte Hans
Chief Financial Officer
Exercise
Calculated transaction value
$0
2,859 shares @ $0
Traded
Oct 30, 2026
Filed
Nov 2, 2026
Van Houte Hans
Chief Financial Officer
Exercise
Calculated transaction value
$0
3,750 shares @ $0
Traded
Oct 30, 2026
Filed
Nov 2, 2026
Van Houte Hans
Chief Financial Officer
Exercise
Calculated transaction value
$0
3,573 shares @ $0
Traded
Oct 30, 2026
Filed
Nov 2, 2026
Van Houte Hans
Chief Financial Officer
Exercise
Calculated transaction value
$0
2,859 shares @ $0
Traded
Oct 30, 2026
Filed
Nov 2, 2026
Van Houte Hans
Chief Financial Officer
Sale
Calculated transaction value
$74.47K
2,834 shares @ $26.28
Traded
Oct 30, 2026
Filed
Nov 2, 2026
Ring Christine
Chief Legal Officer
Exercise
Calculated transaction value
$0
3,573 shares @ $0
Traded
Oct 30, 2026
Filed
Nov 2, 2026
Ring Christine
Chief Legal Officer
Sale
Calculated transaction value
$103.99K
3,957 shares @ $26.28
Traded
Oct 30, 2026
Filed
Nov 2, 2026
Ring Christine
Chief Legal Officer
Exercise
Calculated transaction value
$0
3,750 shares @ $0
Traded
Oct 30, 2026
Filed
Nov 2, 2026
Ring Christine
Chief Legal Officer
Exercise
Calculated transaction value
$0
2,859 shares @ $0
Traded
Oct 30, 2026
Filed
Nov 2, 2026
Ring Christine
Chief Legal Officer
Exercise
Calculated transaction value
$0
2,859 shares @ $0
Traded
Oct 30, 2026
Filed
Nov 2, 2026
Ring Christine
Chief Legal Officer
Exercise
Calculated transaction value
$0
3,750 shares @ $0
Traded
Oct 30, 2026
Filed
Nov 2, 2026
Ring Christine
Chief Legal Officer
Exercise
Calculated transaction value
$0
3,573 shares @ $0
Traded
Oct 30, 2026
Filed
Nov 2, 2026
Hansen Gwenn
Chief Scientific Officer
Exercise
Calculated transaction value
$2.7K
1,452 shares @ $1.86
Traded
Nov 2, 2026
Filed
Nov 2, 2026
Hansen Gwenn
Chief Scientific Officer
Sale
Calculated transaction value
$38.91K
1,452 shares @ $26.8
Traded
Nov 2, 2026
Filed
Nov 2, 2026
Hansen Gwenn
Chief Scientific Officer
Exercise
Calculated transaction value
$0
1,452 shares @ $0
Traded
Nov 2, 2026
Filed
Nov 2, 2026
Hansen Gwenn
Chief Scientific Officer
Exercise
Calculated transaction value
$0
2,859 shares @ $0
Traded
Oct 30, 2026
Filed
Nov 2, 2026
Hansen Gwenn
Chief Scientific Officer
Sale
Calculated transaction value
$103.99K
3,957 shares @ $26.28
Traded
Oct 30, 2026
Filed
Nov 2, 2026
Hansen Gwenn
Chief Scientific Officer
Exercise
Calculated transaction value
$0
3,750 shares @ $0
Traded
Oct 30, 2026
Filed
Nov 2, 2026
Hansen Gwenn
Chief Scientific Officer
Exercise
Calculated transaction value
$0
3,573 shares @ $0
Traded
Oct 30, 2026
Filed
Nov 2, 2026
Hansen Gwenn
Chief Scientific Officer
Exercise
Calculated transaction value
$0
3,750 shares @ $0
Traded
Oct 30, 2026
Filed
Nov 2, 2026
Hansen Gwenn
Chief Scientific Officer
Exercise
Calculated transaction value
$0
3,573 shares @ $0
Traded
Oct 30, 2026
Filed
Nov 2, 2026